As our understanding of neurodegenerative diseases deepens, so does the recognition that the nervous system doesn’t fail all at once—it’s pushed there by a complex web of molecular events. New research is shedding light on how subtle shifts in immune signaling, cell death pathways, and metabolism can tip the balance toward degeneration—or recovery.
In Lewy body dementia, scientists have uncovered how exosomes from activated microglia may accelerate disease by delivering LAG3 to key neurons, promoting harmful α-synuclein uptake. Meanwhile, in spinal cord injury, a plant compound called juglone appears to promote healing by dialing down inflammatory cell death processes. And in ALS, a targeted nanoparticle therapy helps restore metabolic stability in spinal stem cells, potentially improving their regenerative function. Together, these findings underscore a growing trend in neuroscience: tackling disease at the root by decoding—and correcting—the cellular conversations that go awry.
1. Activated microglial exosomes enhance α-Synuclein internalization and accelerate neurodegeneration in lewy body dementia
Exosomes from activated microglia deliver LAG3 to cholinergic neurons in the NBM, enhancing α-synuclein uptake and accelerating neurodegeneration—uncovering a novel mechanism behind cognitive decline in Lewy body dementia.
2. Juglone promotes spinal cord injury recovery by suppressing pyroptosis and necroptosis through FOS/USP53/ubiquitination
Low-dose juglone enhances recovery after spinal cord injury by suppressing pyroptosis and necroptosis through the FOS/USP53/ubiquitination pathway—promoting neuronal survival and functional restoration.
3. Metabolic reprogramming in amyotrophic lateral sclerosis ependymal stem cells by FM19G11 nanotherapy
Anti-BCMA CAR-T therapy in progressive MS patients led to deep plasma cell depletion in the CNS, sustained CAR-T cell presence in cerebrospinal fluid, and reduced neuroinflammation—pointing to a promising strategy for modifying hard-to-treat disease progression.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
